Skip to main content

Birchview Capital, LP

Position in NKTR — Nektar Therapeutics

CIK 1618205 BURLINGTON, VT

Position in NKTR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$5,654,610
+$3,424,160 QoQ
Shares Held
81,000
+161.3% QoQ
Ownership
0.237%
of shares outstanding
% of Portfolio
2.67%
of 13F equity value
Holder Rank
#64
of 239 holders
Holding Since
Mar 2021
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NKTR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Birchview Capital, LP holds $91,246,272 across 49 Biotechnology names. NKTR ranks #4 (6.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 NKTR
Nektar Therapeutics
This page
81,000 $5,654,610

All Filings in NKTR

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,654,610 81,000
2026-03-31 $2,230,450 31,000
2025-12-31 $1,310,680 31,000
2025-09-30 $228,794 4,021
2023-09-30 $16,800 28,000
2023-06-30 $16,240 28,000
2023-03-31 $82,600 118,000
2022-12-31 $266,680 118,000
2022-09-30 $409,600 128,000
2022-06-30 $486,400 128,000
2022-03-31 $689,920 128,000
2021-12-31 $1,351,000 100,000
2021-09-30 $1,293,120 72,000
2021-06-30 $1,235,520 72,000
2021-03-31 $1,840,000 92,000